Skip to main content
. 2018 Oct 10;363:k3870. doi: 10.1136/bmj.k3870

Table 3.

Changes in secondary outcome sitting and physical activity variables at follow-up between participants randomised to usual practice (control) or to the SMArT Work intervention*

Secondary outcomes No of offices (participants) Mean change from baseline (95% CI) Adjusted difference at follow-up†
Control Intervention Control Intervention Coefficient (95% CI) P value
Occupational sitting time (min/workday)
3 months 17 (46) 19 (63) −6.17 (−30.24 to 17.91) −62.09 (−83.89 to −40.30) −50.62 (−78.71 to −22.54) <0.001
6 months 18 (48) 19 (64) −0.25 (−26.17 to 25.67) −61.50 (−86.47 to −36.53) −64.40 (−97.31 to −31.50) <0.001
Daily sitting time (min/day)
3 months 17 (46) 19 (64) −27.57 (−58.6 to 3.43) −49.01 (−69.41 to −28.61) −33.46 (−67.24 to 0.32) 0.05
6 months 18 (49) 19 (64) 4.84 (−24.80 to 34.49) −42.38 (−64.43 to −20.33) −59.32 (−88.40 to −30.25) <0.001
12 months 16 (45) 19 (62) 7.99 (−17.17 to 33.14) −63.03 (−86.01 to −40.04) −82.39 (−114.54 to −50.26) 0.001
Occupational prolonged sitting time (min/workday)
3 months 17 (46) 19 (63) –13.73 (−34.59 to 7.12) −35.77 (−54.83 to −16.71) −17.49 (−44.27 to 9.29) 0.20
6 months 18 (48) 19 (64) −5.12 (−30.09 to 19.86) −40.81 (−60.08 to −21.54) −35.31 (−58.75 to −11.87) 0.003
12 months 16 (45) 19 (62) 3.87 (−24.38 to 32.13) −36.84 (−59.80 to −13.88) −44.93 (−79.67 to −10.20) 0.011
Daily prolonged sitting time (min/day)
3 months 17 (46) 19 (64) −32.19 (−62.56 to −1.81) −41.24 (−61.78 to −20.71) −12.33 (−29.88 to 5.23) 0.17
6 months 18 (49) 19 (64) 1.50 (−24.36 to 27.36) −32.35 (−50.83 to −13.87) −25.38 (−44.66 to −6.10) 0.010
12 months 16 (45) 19 (62) 10.90 (−17.01 to 38.82) −37.19 (−59.45 to −14.93) −58.34 (−91.18 to −25.50) <0.001
Occupational standing time (min/workday)
3 months 17 (46) 19 (63) 7.99 (−16.93 to 32.92) 58.43 (38.18 to 78.67) 48.91 (19.21 to 78.61) <0.001
6 months 18 (48) 19 (64) −3.94 (−27.15 to 19.28) 68.34 (46.59 to 90.09) 72.62 (44.80 to 100.44) <0.001
12 months 16 (45) 19 (62) −4.15 (−28.89 to 20.59) 66.92 (46.04 to 87.80) 66.00 (38.14 to 93.86) <0.001
Daily standing time (min/day)
3 months 17 (46) 19 (64) 14.40 (−8.97 to 37.78) 44.45 (27.35 to 61.53) 36.95 (9.28 to 64.62) 0.009
6 months 18 (49) 19 (64) −7.48 (−31.73 to 16.66) 43.28 (23.39 to 63.18) 55.96 (28.23 to 83.69) <0.001
12 months 16 (45) 19 (62) −6.31 (−28.46 to 15.85) 49.38 (29.08 to 69.67) 62.81 (36.24 to 89.39) <0.001
Occupational stepping time (min/workday)
3 months 17 (46) 19 (63) 1.28 (−2.51 to 5.07) 2.41 (−1.57 to 6.39) 1.33‡ (−2.68 to 5.34) 0.52
6 months 18 (48) 19 (64) 2.26 (−2.13 to 6.65) 4.56 (0.59 to 8.53) 3.56 (−1.18 to 8.30) 0.14
12 months 16 (45) 19 (62) 0.33 (−4.07 to 4.73) −1.61 (−5.70 to 2.48) 0.0003 (−5.15 to 5.15) 1.00
Daily stepping time (min/day)
3 months (min/day) 17 (46) 19 (64) 15.95 (8.26 to 23.64) 8.69 (3.08 to 14.30) −6.44 (−16.16 to 3.28) 0.19
6 months (min/day) 18 (49) 19 (64) 1.29 (−5.76 to 8.35) 5.11 (−0.53 to 10.76) 7.06 (−2.39 to 16.50) 0.14
12 months (min/day) 16 (45) 19 (62) 3.75 (−2.81 to 10.32) 2.63 (−3.35 to 8.61) 1.21 (−8.18 to 10.60) 0.80
Occupational MVPA (ActiGraph) (min/workday)
3 months 17 (43) 19 (61) 3.71 (−4.63 to 12.05) 0.50 (−3.51 to 4.51) −1.72 (−6.68 to 3.23) 0.50
6 months 15 (38) 18 (57) 3.04 (−1.58 to 7.66) 1.39 (−2.63 to 5.40) −0.61 (−7.89 to 6.68) 0.87
12 months 16 (38) 19 (56) 0.12 (−4.04 to 4.30) −0.15 (−4.96 to 4.66) 2.26 (−4.22 to 8.74) 0.49
Daily MVPA (ActiGraph) (min/day)
3 months 17 (45) 19 (64) 10.48 (1.11 to 19.85) −0.38 (−6.22 to 5.46) −9.75 (−20.86 to 1.36) 0.09
6 months 15 (41) 18 (57) 0.44 (−7.88 to 8.76) 1.43 (−5.02 to 7.88) 4.50 (−6.64 to 15.64) 0.43
12 months 16 (39) 19 (56) 0.87 (−7.60 to 9.34) 0.46 (−7.01 to 7.92) 1.01 (−9.27 to 11.29) 0.85

MVPA=moderate to vigorous physical activity.

*

Including participants who have worn the accelerometer with a minimum of one valid day at baseline and three months, baseline and six months, and baseline and 12 months.

Adjusted difference in mean sitting at follow-up between treatment groups with 95% confidence interval, P value; adjusted for cluster effect, baseline sitting, average activPAL wear time during work hours/activPAL waking wear time across baseline and three months, average activPAL wear time during work hours/activPAL waking wear time across baseline and six months, average activPAL wear time during work hours/activPAL waking wear time across baseline and 12 months and stratification categories (cluster size ≤4 and >4 participants).

Used independent correlation structure. Model did not converge with exchangeable correlation structure.